Fish & Richardson P.C.
Treating atherosclerosis
The present application features methods and compositions for treating patients suffering from atherosclerosis or at risk for developing atherosclerosis. The treatment includes administering to the patient a pharmaceutical composition that includes an agent capable of blocking the interaction between uPA and its receptor uPAR, e.g., an ATF or a fragment thereof, an anti-uPA antibody, a uPAR or a fragment thereof, or an antibody that specifically binds to uPAR.
Landing Biotech, Inc.
C C A A
C12N C12Y A61P A61K
inventional inventional inventional additional
Jian-Ning
Liu